Is microfluidics the "assembly line" for CRISPR-Cas9 gene-editing?

Area of Science:

• Biotechnology
• Molecular Biology
• Bioengineering

Background:

• CRISPR technology has revolutionized biotechnology, enabling gene therapy and organism modification.
• The CRISPR-Cas9 system offers versatility, including gene activation, repression, knockout, and knockin.
• Current gene-editing workflows face limitations that hinder broader application.

Purpose of the Study:

• To describe efforts in automating the gene-editing workflow.
• To highlight the role of microfluidic technology in CRISPR automation.
• To discuss how automation and microfluidics can expand CRISPR applications.

Main Methods:

• Review of current automation strategies in gene editing.
• Emphasis on the integration of microfluidic devices for enhanced gene editing.
• Analysis of how automation addresses limitations in CRISPR technology.

Main Results:

• Automation streamlines the gene-editing process, increasing efficiency and versatility.
• Microfluidic technology offers precise control and scalability for gene-editing applications.
• The combination of automation and microfluidics overcomes existing bottlenecks in CRISPR workflows.

Conclusions:

• Automating CRISPR gene editing, especially with microfluidics, is crucial for advancing biotechnology.
• This integration promises to unlock new therapeutic and industrial applications for CRISPR.
• The synergy between microfluidics and gene editing will accelerate scientific discovery and innovation.